You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MSH6

Showing 1 - 25 of 138
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lynch Syndrome, Lynch Syndrome I, Lynch Syndrome II Trial in Milan (Video capsule endoscopy)

Recruiting
  • Lynch Syndrome
  • +7 more
  • Video capsule endoscopy
  • Milan, Lombardia, Italy
    San Raffaele Scientific Institute, Gastroenterology and Gastroin
Jan 27, 2023

BARD1 Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston, Seattle (Educational Intervention, Genetic

Recruiting
  • BARD1 Gene Mutation
  • +14 more
  • Educational Intervention
  • +3 more
  • Houston, Texas
  • +1 more
Jun 14, 2022

An Intervention to Increase Genetic Testing in Families Who May

Recruiting
  • BRCA1 Mutation
  • +21 more
  • Intervention Arm At-risk Relative/ARR Contacts
  • +5 more
  • Basking Ridge, New Jersey
  • +7 more
Nov 22, 2022

Cascade Testing in Families With Newly Diagnosed Hereditary

Recruiting
  • BRCA-Mutated Ovarian Carcinoma
  • +7 more
  • CASCADE genetic screening
  • New York, New York
    NYU Langone Health
Apr 30, 2021

Deleterious BARD1 Gene Mutation, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation Trial in United States

Active, not recruiting
  • Deleterious BARD1 Gene Mutation
  • +13 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Chicago, Illinois
  • +8 more
Feb 25, 2022

EPP, XLP Trial in Worldwide (MT-7117)

Active, not recruiting
  • EPP
  • XLP
  • Huntington Beach, California
  • +30 more
Oct 24, 2022

EPP, XLP Trial in Worldwide (Placebo, MT-7117 Low Dose, MT-7117 High Dose)

Active, not recruiting
  • EPP
  • XLP
  • Placebo
  • +2 more
  • Huntington Beach, California
  • +30 more
Feb 15, 2022

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Rochester (Bio-specimen Collection: Blood, Bio-specimen

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Bio-specimen Collection: Blood
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 21, 2023

Metastatic Carcinoma in the Liver, MLH1 Gene Mutation, MSH6 Gene Mutation Trial in Duarte (Durvalumab, Laboratory Biomarker

Completed
  • Metastatic Carcinoma in the Liver
  • +6 more
  • Durvalumab
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Dec 23, 2019

Germline Mutations Associated With Hereditary Pancreatic Cancer

Recruiting
  • Pancreatic Cancer
  • Pancreatic Adenocarcinoma
  • Invitae Multi-Cancer Panel ®
  • Mexico City, Mexico
    Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Mar 22, 2022

Precision-Based Genomics in Prostate Cancer

Recruiting
  • Prostate Cancer
    • La Jolla, California
    • +4 more
    Jul 28, 2022

    Carcinogenesis-related Molecular Markers in Colon Cancer and

    Active, not recruiting
    • Colorectal Cancer
    • Colorectal Adenoma
      • Seongnam-si, Gyeonggi-do, Korea, Republic of
        Seoul National University Bundang Hospital
      Nov 27, 2022

      Pancreas Cancer, Exosomes, Extracellular Vesicles Trial

      Not yet recruiting
      • Pancreas Cancer
      • +3 more
        • (no location specified)
        Dec 6, 2022

        Endometrial Tumors, Endometrial Tumor Malignant, Endometrial Tumor Malignant Stage I Trial in Beijing (Indication-extended

        Recruiting
        • Endometrial Neoplasms
        • +4 more
        • Indication-extended Fertility-sparing Therapy
        • Beijing, Beijing, China
          Peking University People's Hosoital
        Jul 12, 2023

        Pancreatic Cancer Early Detection Consortium

        Recruiting
        • Pancreas Cancer
        • +3 more
          • Duarte, California
          • +29 more
          Jul 14, 2022

          Metastatic Colorectal Cancer Trial in Milan (Temozolomide, Nivolumab, Ipilimumab)

          Completed
          • Metastatic Colorectal Cancer
          • Milan, MI, Italy
            Fondazione IRCCS Istituto Nazionale dei Tumori
          Apr 1, 2022

          Metastatic Colorectal Cancer Trial run by the National Cancer Institute (NCI) (Retifanlimab, Therapeutic CEA, Brachyury and MUC1

          Not yet recruiting
          • Metastatic Colorectal Cancer
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Dec 4, 2023

          Solid Tumor, Unspecified, Adult, Haematological Malignancy Trial in Aalborg

          Recruiting
          • Solid Tumor, Unspecified, Adult
          • Haematological Malignancy
            • Aalborg, Denmark
              Department of Oncology, Aalborg University Hospital
            Jan 20, 2023

            Metastatic Colorectal Cancer Trial in France (Nivolumab, Ipilimumab)

            Recruiting
            • Metastatic Colorectal Cancer
            • Besançon, France
            • +5 more
            May 6, 2022

            Colorectal Cancer, Lynch Syndrome, Hereditary Colorectal Cancer Trial in Moscow

            Not yet recruiting
            • Colorectal Cancer
            • +3 more
              • Moscow, Russian Federation
                State Scientific Centre of Coloproctology
              Aug 8, 2022

              Lynch Syndrome Trial in Bobigny (Acetylsalicylic acid lysinate 300 mg, Placebo (for Aspirin 300), Acetylsalicylic acid lysinate

              Recruiting
              • Lynch Syndrome
              • Acetylsalicylic acid lysinate 300 mg
              • +3 more
              • Bobigny, France
                Hôpital Avicenne
              Jun 27, 2022

              Men at High Genetic Risk for Prostate Cancer

              Recruiting
              • Prostatic Neoplasms
                • Bethesda, Maryland
                  National Institutes of Health Clinical Center
                Jan 25, 2023

                Colorectal Cancers With Microsatellite Instability

                Active, not recruiting
                • Colorectal Cancer
                • Microsatellite Instability
                  • Poitiers, Vienne, France
                  • +13 more
                  Aug 19, 2022

                  Cell-free DNA in Hereditary And High-Risk Malignancies

                  Recruiting
                  • Hereditary Cancer Syndrome
                  • Next generation sequencing (NGS)
                  • Vancouver, British Columbia, Canada
                  • +6 more
                  Feb 14, 2022

                  Lynch Syndrome Trial in Philadelphia (Atorvastatin 20mg, Atorvastatin 20mg AND Aspirin 325 mg)

                  Recruiting
                  • Lynch Syndrome
                  • Atorvastatin 20mg
                  • Atorvastatin 20mg AND Aspirin 325 mg
                  • Philadelphia, Pennsylvania
                    Fox Chase Cancer Center
                  Apr 6, 2022